title: No better than less expensive drugs.
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Perry
authors.forename: Stephen S
authors.initials: SS
authors.lastname: Lippman
authors.forename: Mark
authors.initials: M
authors.lastname: McConnell
authors.forename: Aaron M
authors.initials: AM
authors.lastname: Tejani
mesh_terms: D003362:Cost-Benefit Analysis; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics* / Q000627:therapeutic use
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents